If you have been reading about angiotensin IV and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-02-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.
Discussion in the literature often separates direct receptor activation from downstream growth-factor modulation. Dihexa is not simply an angiotensin receptor blocker or a classic nootropic drug. Its proposed action may depend on endogenous HGF levels, which vary by tissue and physiological state. Questions remain about brain penetration, metabolic stability, and active metabolites. Reviews note that mechanistic claims should be treated as hypotheses until supported by independent studies. That distinction is important when interpreting promotional claims or early laboratory findings.
| Property | Value | Notes |
|---|---|---|
| Development status | Preclinical research | No approved therapeutic indication has been established. |
| Human data | Limited or absent | Published controlled trials in people are not available. |
| Regulatory classification | Varies by country | Often treated as a research chemical rather than a medicine. |
| Common supply form | Lyophilized powder | Sold for laboratory use, not for human consumption. |
| Quality checks | Certificate of analysis; HPLC; mass spectrometry | Used to verify identity and purity in research settings. |
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
Resonance ionization is a process in optical physics used to excite a specific atom (or molecule) beyond its ionization potential to form an ion using a beam of photons irradiated from a pulsed laser light. In resonance ionization, the absorption or emission properties of the emitted photons are not considered, rather only the resulting excited ions are mass-selected, detected and measured. Depending on the laser light source used, one electron can be removed from each atom so that resonance ionization produces an efficient selectivity in two ways: elemental selectivity in ionization and isotopic selectivity in measurement. During resonance ionization, an ion gun or desorption laser creates a cloud of atoms and molecules from a solid surface or gas-phase sample before a tunable laser is used to fire a beam of photons at the cloud of particles emanating from the sample (analyte). An initial photon from this beam is absorbed by one of the sample atoms, exciting one of the atom's electrons to an intermediate excited state. A second photon then ionizes the same atom from the intermediate state such that its high energy level causes it to be ejected from its orbital; the result is a packet of positively charged ions which are then delivered to a mass analyzer. Resonance ionization contrasts with resonance-enhanced multiphoton ionization (REMPI) in that the latter is neither selective nor efficient since resonances are seldom used to prevent interference. Also, resonance ionization is used for an atomic (elemental) analyte, whereas REMPI is used for a molecular analyte.
The dynamics of an epidemic, for example, the flu, are often much faster than the dynamics of birth and death, therefore, birth and death are often omitted in simple compartmental models. The SIR system without so-called vital dynamics (birth and death, sometimes called demography) described above can be expressed by the following system of ordinary differential equations:
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1 (GLP-1).
== Arts and entertainment == Eighth octave C, a musical note, the highest on a piano Castle Infinity, the first graphical massively multiplayer online game C8 (French TV channel), a defunct French TV channel C8 (Eastern Europe), TV channel
Sources: en.wikipedia.org
=== Limitation of structure databases === Structure databases are orders of magnitude larger than spectral libraries but still incomplete. It is understood that not every existing biomolecule is or will be contained in structure databases. For these instances, SIRIUS offers several solutions:
==== France ==== The French Institute of International Relations (IFRI) was founded in 1979 and is the third oldest think tank of western Europe, after Chatham House (UK, 1920) and the Stockholm International Peace Research Institute (Sweden, 1960). The primary goals of IFRI are to develop applied research in the field of public policy related to international issues, and foster interactive and constructive dialogue between researchers, professionals, and opinion leaders. France also hosts the European Union Institute for Security Studies (EUISS), a Paris-based agency of the European Union and think tank researching security issues of relevance for the EU. There are also a number of pro-business think tanks, notably the Paris-based Fondation Concorde. The foundation focuses on increasing the competitiveness of French SME's and aims to revive entrepreneurship in France. On the left, the main think tanks in France are the Fondation Jean-Jaurès, which is organizationally linked to the French Socialist Party, and Terra Nova. Terra Nova is an independent left-leaning think tank, although it is nevertheless considered to be close to the Socialists. It works on producing reports and analyses of current public policy issues from a progressive point of view, and contributing to the intellectual renewal of social democracy.
=== Land mine usage === Since 1990, over 11,000 people have been killed or wounded by landmines in Colombia. According to the Presidential Program for Mine Action, between 1982 and the end of 2012, 2,038 people were killed by landmines. Since 2000, casualties from landmines in Colombia have ranged from 1,300 a year to around 550. In the past, the Colombian government laid landmines around 34 military bases to protect key infrastructure, but it renounced their use in 1997. Landmines are primarily used by rebel groups to protect their home bases and illegal drug crops, which fund the conflict. FARC and ELN have deployed antipersonnel mines throughout an estimated area of up to 100 square kilometers. In March 2015, FARC stated that it would begin humanitarian demining in selected parts of Colombia.
Sources: en.wikipedia.org
=== Pharmacodynamics === NM-2-AI acts as a highly selective norepinephrine reuptake inhibitor and releasing agent in vitro and does not release serotonin or dopamine even at very high concentrations (100 μM). NM-2AI has high affinity (2.4 μM IC50) as a norepinephrine reuptake inhibitor but also has affinity as a TAAR1 receptor agonist (3.3 μM EC50), an Alpha-2A adrenergic receptor agonist (0.49 μM Ki) and as a binding agent at the 5-HT1A (3.6 μM Ki) and 5-HT2A (5.4 μM Ki) receptors.
BCG vaccine Cholera vaccine Dengue vaccine Diphtheria vaccine Ebola vaccine Haemophilus influenzae type b vaccine Hepatitis A vaccine Hepatitis B vaccine Hepatitis E vaccine Human papilloma virus (HPV) vaccine Influenza vaccine (seasonal) Japanese encephalitis vaccine Malaria vaccine Measles vaccine Meningococcal meningitis vaccine Mpox vaccine Mumps vaccine Pertussis vaccine Pneumococcal vaccine Poliomyelitis vaccine Rabies vaccine Respiratory syncytial virus vaccine Rotavirus vaccine Rubella vaccine Tetanus vaccine Tick-borne encephalitis vaccine Typhoid vaccine Varicella vaccine Yellow fever vaccine
This ATP synthesis reaction is called the binding change mechanism and involves the active site of a β subunit cycling between three states. In the "open" state, ADP and phosphate enter the active site (shown in brown in the diagram). The protein then closes up around the molecules and binds them loosely – the "loose" state (shown in red). The enzyme then changes shape again and forces these molecules together, with the active site in the resulting "tight" state (shown in pink) binding the newly produced ATP molecule with very high affinity. Finally, the active site cycles back to the open state, releasing ATP and binding more ADP and phosphate, ready for the next cycle. In some bacteria and archaea, ATP synthesis is driven by the movement of sodium ions through the cell membrane, rather than the movement of protons. Archaea such as Methanococcus also contain the A1Ao synthase, a form of the enzyme that contains additional proteins with little similarity in sequence to other bacterial and eukaryotic ATP synthase subunits. It is possible that, in some species, the A1Ao form of the enzyme is a specialized sodium-driven ATP synthase, but this might not be true in all cases.
At Leeds Crown Court, Piran Ditta Khan, who planned the 2005 robbery during which PC Sharon Beshenivsky was shot dead, is convicted of her murder. He is the last of the seven-member gang involved in the robbery to stand trial. The deadline for installing new scanners at airports is extended, meaning airline passengers at major airports will continue to face limits on the amount of liquid they can carry in hand luggage. The Met Office issues a yellow severe weather warning for wintry showers and high winds ahead of the arrival of Storm Kathleen, expected to reach the UK on 6 April. 5 April – John Tinniswood, a great-grandfather from Merseyside, officially becomes the world's oldest living man at the age of 111 years and 283 days. 6 April Former Prime Minister Boris Johnson describes calls for the UK to end arms sales to Israel as "shameful". Two planes collide at Heathrow Airport causing damage to both aircraft, but there are no injuries to people on board. 7 April Deputy Prime Minister Oliver Dowden tells the BBC he still believes it is legal for the UK to sell arms to Israel. Analysis by BBC News suggests that those running the Post Office were paid £19.4m during the 24 years of the Horizon IT scandal. 8 April Westernmost parts of the UK experience a partial solar eclipse. William Wragg steps down as vice chairman of the 1922 Committee of Tory MPs, after sharing MPs' personal phone numbers with someone on a dating app. 9 April Widespread travel and other disruption is reported around the UK, following an exceptionally high tide combined with strong winds.
Sources: en.wikipedia.org
Published human trials are lacking. Most evidence comes from laboratory and animal studies. Therefore, human benefits and risks are not established.
Rules differ by country and by how the product is labeled. Research chemicals are often sold for laboratory use only. Buyers should check local regulations before ordering.
Some animal studies have examined cognitive outcomes, which has led to online interest. These results do not prove cognitive enhancement in people. The term nootropic is not a regulatory category.
It is thought to enhance hepatocyte growth factor signaling through the c-Met receptor. This pathway is involved in cell growth and repair. The precise molecular details are not fully established.